Abbott Laboratories Share Price

Equities

ABT

US0028241000

Medical Equipment, Supplies & Distribution

Market Closed - Nyse 01:30:01 16/05/2024 am IST 5-day change 1st Jan Change
104.6 USD +0.56% Intraday chart for Abbott Laboratories -0.33% -4.98%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
Sales 2024 * 4.17TCr 3,47800Cr Sales 2025 * 4.47TCr 3,73200Cr Capitalization 18TCr 15,09000Cr
Net income 2024 * 596.2Cr 50TCr Net income 2025 * 718.4Cr 60TCr EV / Sales 2024 * 4.47 x
Net Debt 2024 * 547.18Cr 46TCr Net cash position 2025 * 64Cr 5.34TCr EV / Sales 2025 * 4.03 x
P/E ratio 2024 *
30.4 x
P/E ratio 2025 *
25.9 x
Employees 1,14,000
Yield 2024 *
2.08%
Yield 2025 *
2.23%
Free-Float 86.96%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.56%
1 week-0.33%
Current month-1.30%
1 month-3.95%
3 months-7.96%
6 months+6.72%
Current year-4.98%
More quotes
1 week
103.36
Extreme 103.36
105.67
1 month
103.36
Extreme 103.36
108.72
Current year
103.36
Extreme 103.36
121.64
1 year
89.67
Extreme 89.674
121.64
3 years
89.67
Extreme 89.674
142.60
5 years
61.61
Extreme 61.61
142.60
10 years
36.00
Extreme 36
142.60
More quotes
Managers TitleAgeSince
Chief Executive Officer 50 01/15/01
Director of Finance/CFO 51 01/97/01
Chief Tech/Sci/R&D Officer - 01/90/01
Members of the board TitleAgeSince
Director/Board Member 69 16/17/16
Director/Board Member 63 29/17/29
Director/Board Member 65 09/11/09
More insiders
Date Price Change Volume
15/24/15 104.6 +0.56% 5,318,207
14/24/14 104 -0.73% 7,035,128
13/24/13 104.8 +0.03% 5,459,183
10/24/10 104.7 +0.07% 7,349,729
09/24/09 104.7 -0.26% 5,902,240

Delayed Quote Nyse, May 16, 2024 at 01:30 am IST

More quotes
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
104.6 USD
Average target price
126.1 USD
Spread / Average Target
+20.61%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW